Yale Jen
Stock Analyst at Laidlaw & Co.
(0.84)
# 3,960
Out of 5,042 analysts
14
Total ratings
14.29%
Success rate
-4.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSRX Nasus Pharma | Initiates: Buy | $22 | $7.89 | +178.83% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $2.08 | +140.38% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $64.18 | +63.60% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $6.18 | +207.44% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.65 | +1,443.21% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $90.76 | -47.11% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.58 | +4,210.34% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.14 | +10,414.02% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $3.86 | - | 2 | Dec 22, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $0.59 | +1,581.24% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.82 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $1.30 | +18,361.54% | 1 | Sep 6, 2022 |
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $7.89
Upside: +178.83%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $64.18
Upside: +63.60%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $6.18
Upside: +207.44%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.65
Upside: +1,443.21%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $90.76
Upside: -47.11%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.58
Upside: +4,210.34%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.14
Upside: +10,414.02%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.86
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.59
Upside: +1,581.24%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.82
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.30
Upside: +18,361.54%